Natco Pharma informs about compliance report

20 May 2021 Evaluate
Natco Pharma has informed that it enclosed Annual Secretarial Compliance Report for the year ended March 31, 2021, as per Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) read with SEBI Circular No. CIR/CFD/CMDI/27/2019 dated February 8, 2019 for the year ended March 31, 2021.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

898.80 -34.80 (-3.73%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×